Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 13 of 100
Politics
Biden’s plan to save money on Medicare drugs risks leaving shelves empty, pharmacists say
By
Susan Jaffe
and
KFF Health News
June 11, 2024
Health
Alzheimer’s drug from Eli Lilly that can slow brain-robbing disease backed by FDA advisers
By
Matthew Perrone
and
The Associated Press
June 11, 2024
Newsletters
Female CEOs used to run America’s top drugstores. But two powerful women were replaced this year as pharmacies face a national crisis
By
Maria Aspan
and
Joey Abrams
June 7, 2024
Health
‘You’re the smoking cessation counselor, you’re the suicide prevention counselor’—waves of pharmacy closures nationwide take a toll
By
The Associated Press
,
Tom Murphy
and
Kasturi Pananjady
June 3, 2024
Newsletters
Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
By
Peter Vanham
and
Nicholas Gordon
May 29, 2024
Retail
Danish pharma giant Novo Nordisk’s office building is in danger of collapsing after a ‘massive fire’ broke out
By
Sanne Wass
,
Naomi Kresge
and
Bloomberg
May 23, 2024
Health
GLP-1 drugs like Wegovy are all the rage—but people are quitting them too fast to achieve meaningful weight loss, finds 170,000-patient study
By
Lindsey Leake
May 22, 2024
Health
How GSK CEO Emma Walmsley kept her job and turned a belligerent activist investor into an ally
By
Ashleigh Furlong
,
Sabah Meddings
and
Bloomberg
May 21, 2024
Finance
Denmark’s economy shrinks 1.8% on reduced pharma production, showing extent of Novo Nordisk dependency
By
Sanne Wass
and
Bloomberg
May 21, 2024
Retail
AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030
By
Ashleigh Furlong
and
Bloomberg
May 21, 2024
Health
Hims will follow its Viagra playbook and offer weight-loss drugs that are 85% cheaper than Wegovy—with Mounjaro and Zepbound in its sights next
By
Madison Muller
,
Jessica Nix
and
Bloomberg
May 20, 2024
Health
Weaning off Ozempic slowly instead of quitting abruptly can help prevent patients from regaining weight, study says
By
Ashleigh Furlong
and
Bloomberg
May 12, 2024
Tech
Google DeepMind and Isomorphic Labs reveal AI able to predict large swathes of molecular biology
By
Jeremy Kahn
May 8, 2024
Newsletters
How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss drugs
By
Sheryl Estrada
May 3, 2024
Health
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
By
Sunny Nagpaul
May 2, 2024
Most Popular
North America
Gates Foundation plans to give away $9 billion in 2026 to prepare for the 2045 closure while slashing hundreds of jobs
By
Sydney Lake
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By
Preston Fore
Personal Finance
Sweden abolished its wealth tax 20 years ago. Then it became a 'paradise for the super-rich'
By
Miranda Sheild Johansson
and
The Conversation